skip to main content





Back to all Representative Matters
Jul 6, 2018

Natural Medco Ltd. Completes $20.8 Million Private Placement and Eve & Co Incorporated Completes Qualifying Transaction and Initial TSXV Listing

Richard M. Kimel, Sherri M. Altshuler, Christopher F. Berrigan, Daniel Everall and Francesco Gucciardo

On June 15, 2018, Natural MedCo Ltd. (formerly 1600978 Ontario Inc.) (“Natural MedCo” or the “Target”) completed a brokered private placement of 25,340,000 subscription receipts at a price of $0.25 per subscription receipt and a non-brokered private placement of 17,852,600 common shares at a price of $0.25 per share for gross proceeds of approximately $10.8 million. Concurrently with the closing of the brokered private placement, Natural MedCo completed a private placement of 10,000 debenture units comprised of convertible debentures and common share purchase warrants for gross proceeds of $10 million.

On June 28, 2018, Eve & Co Incorporated (formerly Carlaw Capital V Corp.) (“EVE”) completed its qualifying transaction with the Target, which consisted of the acquisition of all issued and outstanding common shares of the Target by way of a “three-cornered amalgamation” pursuant to the Business Corporations Act (Ontario).

EVE, through its wholly owned subsidiary Natural MedCo, is a licensed producer and seller of dried cannabis and cannabis plants under the Access to Cannabis for Medical Purposes Regulations. On July 4, 2018, EVE began trading on the TSX Venture Exchange under the ticker symbol “EVE”.

Aird & Berlis LLP represented EVE and Natural MedCo with a team comprised of Richard Kimel, Sherri Altshuler, Chris Berrigan and Daniel Everall (Capital Markets) and Francesco Gucciardo (Tax).

Areas of Expertise

Related Industries

Related Representative Matters

Representative Matters
Allied Properties REIT Completes $155 Million Public Equity Offering Margaret T. Nelligan, Sherri M. Altshuler, Anne E. Miatello, Melanie Cole, Liam Tracey-Raymont, Amy Marcen-Gaudaur, Michael D. Smith, Aaron Silver and Barbara Worndl Oct 02, 2018 Allied Properties Real Estate Investment Trust, a leading owner, manager and developer of urban office environments operating in Canada’s major cities, recently completed a $155 million public equity offering of units.
Representative Matters
Medipharm Labs Inc. Completes $22.3 Million Private Placement Melanie Cole, Daniel Everall, Amy Marcen-Gaudaur, Barbara Worndl and Damian Lu Aug 01, 2018 On June 29, 2018, MediPharm Labs Inc. completed a private placement of 2,070,571 units at a price of $10.778 per Unit for aggregate proceeds of approximately $22,316,600 in connection with its proposed business combination with POCML4 Inc.
Representative Matters
Baylin Technologies Inc. Completes $40.25 Million Bought Deal Offering and Acquisition of Alga Microwave Inc. Richard M. Kimel, Sherri M. Altshuler, Sean Mason, Christopher F. Berrigan, Aaron Baer, Amy Marcen-Gaudaur, Aaron T. Collins, Kyle B. Plunkett, Alyssa Gebert, Francesco Gucciardo and Stacey Blydorp Jul 18, 2018 Baylin Technologies Inc., a diversified leading global wireless technology management company, recently completed a $40.25 million bought deal public offering of subscription receipts and 6.5% extendible convertible unsecured debentures and the related acquisition of Alga Microwave Inc.